Oracle announces agentic AI capabilities for Oracle AI Database, including Private Agent Factory, Deep Data Security, and ...

Oracle has added Cerebras AI chips to its cloud infrastructure, alongside Nvidia and AMD hardware. Oracle, CEO Clay Magouyrk, said that Oracle is utilising these chips to deliver AI workloads and ...

In today’s business world, getting different software systems to talk to each other can be a real headache. You’ve got your sales system, your accounting software, maybe something for customer service ...

Oracle (ORCL) reported Q3 IaaS revenue of $4.89B, up 84% year over year, with Remaining Performance Obligations surging to $553B (up 325% year over year) driven by large-scale AI contracts. Nebius ...

Enterprise software company Oracle is planning thousands of job cuts as it faces a cash crunch from a massive AI data center expansion effort, Bloomberg News reported Thursday. Long a smaller ...

Oracle Corp. shares soared as much as 15% on Wednesday after the software and cloud services company reported strong sales and issued an outlook that suggests little letup in demand for AI computing.

I’ve always believed that creating loyal customers goes beyond providing good service—it’s about making meaningful connections. In my years of working with companies on customer service strategies, ...

Iran’s Islamic Revolutionary Guard Corps (IRGC) has escalated its rhetoric. The IRGC-affiliated Tasnim news agency has published a list identifying offices tied to several major U.S. technology ...

Welcome to the stage, NVIDIA Founder and CEO, Jensen Huang. Welcome to GTC. I just want to remind you, this is a tech conference. All these people are lining up so early in the morning, all of you in ...

Vast Data expands AI Operating System with global control plane, zero-trust agent framework and deeper Nvidia integration - SiliconANGLE ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2. “In ...